Figures & data
Table 1 Epidemiological characteristics and outcomes of episodes of Pseudomonas aeruginosa cUTI and cUTI due to other etiologies
Table 2 Microbiological features of cUTI episodes with or without Pseudomonas aeruginosa
Table 3 Antibiotic-resistance profile of Pseudomonas aeruginosa complicated urinary tractinfection episodes (n=97)
Table 4 Predictive factors of Pseudomonas aeruginosa complicated urinary tractinfection episodes: mixed-effect logistic regression model
Figure 1 Prevalence with 95% CIs of Pseudomonas aeruginosa complicated urinary tract-infection episodes by centers (A–R) and countries.
![Figure 1 Prevalence with 95% CIs of Pseudomonas aeruginosa complicated urinary tract-infection episodes by centers (A–R) and countries.](/cms/asset/d3f01293-0b98-489e-829d-40bb52c246a1/didr_a_185753_f0001_b.jpg)
Table 5 Predictive factors of multidrug-resistant Pseudomonas aeruginosa: mixed-effect logistic regression model
Figure 2 Prevalence with 95% CIs of multidrug-resistant Pseudomonas aeruginosa complicated urinary tract infection by country.
![Figure 2 Prevalence with 95% CIs of multidrug-resistant Pseudomonas aeruginosa complicated urinary tract infection by country.](/cms/asset/e5eae4ba-4137-449e-b401-1dd3cfa21a9a/didr_a_185753_f0002_b.jpg)
Table 6 Outcomes of episodes of Pseudomonas aeruginosa cUTI and episodes of cUTI caused by other etiologies
Table S1 Univariate analysis of risk factors associated with MDR Pseudomonas aeruginosa cUTI compared to non-MDR P. aeruginosa cUTI, accounting for country effect
Table S2 ICD9 data
Table S3 ICD data